Literature DB >> 20978554

Osteoporosis and gastrointestinal disease.

Seymour Katz1, Stuart Weinerman.   

Abstract

Gastrointestinal disease is often overlooked or simply forgotten as a cause of osteoporosis. Yet, the consequences of osteoporotic fractures can be devastating. Although the bulk of the published experience regarding osteoporosis is derived from the postmenopausal population, this review will focus on gastrointestinal disorders implicated in osteoporosis, with an emphasis on inflammatory bowel disease and celiac disease. The unique aspects of gastrointestinal diseases associated with osteoporosis include early onset of disease (and, therefore, prolonged exposure to risk factors for developing osteoporosis, particularly with inflammatory bowel disease and celiac disease), malabsorption, and maldigestion of nutrients necessary for bone health and maintenance (eg, calcium, vitamin D), as well as the impact of glucocorticoids. These factors, when added to smoking, a sedentary lifestyle, hypogonadism, and a family history of osteoporosis, accumulate into an imposing package of predictors for osteoporotic fracture. This paper will review the identification and treatment strategies for patients with gastrointestinal disorders and osteoporosis.

Entities:  

Keywords:  Crohn's disease; Osteoporosis; RANK/RANKL; celiac disease; malabsorption; ulcerative colitis; vitamin D

Year:  2010        PMID: 20978554      PMCID: PMC2950667     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  130 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

2.  A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.

Authors:  C H Chesnut; S Silverman; K Andriano; H Genant; A Gimona; S Harris; D Kiel; M LeBoff; M Maricic; P Miller; C Moniz; M Peacock; P Richardson; N Watts; D Baylink
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

Review 3.  Bisphosphonates: mechanisms of action.

Authors:  G A Rodan; H A Fleisch
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

4.  Fracture risk is increased in Crohn's disease, but not in ulcerative colitis.

Authors:  P Vestergaard; K Krogh; L Rejnmark; S Laurberg; L Mosekilde
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

5.  A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease.

Authors:  Sandra Henderson; Neville Hoffman; Richard Prince
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

6.  High prevalence of bone disorders after gastrectomy.

Authors:  T T Zittel; B Zeeb; G W Maier; G W Kaiser; M Zwirner; H Liebich; M Starlinger; H D Becker
Journal:  Am J Surg       Date:  1997-10       Impact factor: 2.565

7.  Bone mineral density among cirrhotic patients awaiting liver transplantation.

Authors:  Rana Paramvir Sokhi; Abhinandana Anantharaju; Ravi Kondaveeti; Steven D Creech; Khondker K Islam; David H Van Thiel
Journal:  Liver Transpl       Date:  2004-05       Impact factor: 5.799

8.  Effect of antitumour necrosis factor-alpha therapy on bone turnover in patients with active Crohn's disease: a prospective study.

Authors:  B M Ryan; M G V M Russel; L Schurgers; M Wichers; J Sijbrandij; R W Stockbrugger; E Schoon
Journal:  Aliment Pharmacol Ther       Date:  2004-10-15       Impact factor: 8.171

9.  Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease.

Authors:  Pieter C F Stokkers; Maartje Deley; Mirjam Van Der Spek; Hein J Verberne; Sander J H Van Deventer; Daniel W Hommes
Journal:  Scand J Gastroenterol       Date:  2006-02       Impact factor: 2.423

10.  The association between corticosteroid use and development of fractures among IBD patients in a population-based database.

Authors:  Charles N Bernstein; James F Blanchard; Colleen Metge; Marina Yogendran
Journal:  Am J Gastroenterol       Date:  2003-08       Impact factor: 10.864

View more
  22 in total

1.  Prevention, detection, and treatment of osteopenia and osteoporosis.

Authors:  Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-03

2.  Evaluating bone health in inflammatory bowel disease--a single tertiary care Veterans Hospital experience.

Authors:  Jeffrey A Gill; Susan Goldsmith; Ambuj Kumar
Journal:  Indian J Gastroenterol       Date:  2015-05

3.  Prediction of low bone mineral density in patients with inflammatory bowel diseases.

Authors:  Solvey Schüle; Jean-Benoît Rossel; Diana Frey; Luc Biedermann; Michael Scharl; Jonas Zeitz; Natália Freitas-Queiroz; Valérie Pittet; Stephan R Vavricka; Gerhard Rogler; Benjamin Misselwitz
Journal:  United European Gastroenterol J       Date:  2016-06-30       Impact factor: 4.623

Review 4.  Bone disease in chronic pancreatitis.

Authors:  Awais Ahmed; Aman Deep; Darshan J Kothari; Sunil G Sheth
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

5.  The atherogenic Scarb1 null mouse model shows a high bone mass phenotype.

Authors:  Corine Martineau; Louise Martin-Falstrault; Louise Brissette; Robert Moreau
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-11-19       Impact factor: 4.310

Review 6.  Management of osteoporosis among the elderly with other chronic medical conditions.

Authors:  Jeffrey R Curtis; Monika M Safford
Journal:  Drugs Aging       Date:  2012-07-01       Impact factor: 3.923

7.  Possible antiosteoporotic mechanism of Cicer arietinum extract in ovariectomized rats.

Authors:  Sohair R Fahmy; Amel M Soliman; Amany A Sayed; Mohamed Marzouk
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 8.  Epithelial Barrier Function in Gut-Bone Signaling.

Authors:  Naiomy Deliz Rios-Arce; Fraser L Collins; Jonathan D Schepper; Michael D Steury; Sandi Raehtz; Heather Mallin; Danny T Schoenherr; Narayanan Parameswaran; Laura R McCabe
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

9.  The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database.

Authors:  Gyu Lee Kim; Yu Hyeon Yi; Hye Rim Hwang; Jinmi Kim; Youngmin Park; Yun Jin Kim; Jeong Gyu Lee; Young Jin Tak; Seung Hun Lee; Sang Yeoup Lee; Youn Hye Cho; Eun Ju Park; Youngin Lee
Journal:  J Clin Med       Date:  2021-05-10       Impact factor: 4.241

10.  Effect of high-dose vitamin D3 intake on ambulation, muscular pain and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report.

Authors:  Barbara M van Amerongen; François Feron
Journal:  Int J Mol Sci       Date:  2012-10-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.